cbdMD (YCBD) Revenue Growth (1y) (2017 - 2025)
cbdMD (YCBD) Revenue Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 14.92% |
| 10 | cbdMD | 4.66 Mn | 1.27 Mn | 3.00 Mn | -1.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.89% |
| Sep 30, 2025 | -5.52% |
| Jun 30, 2025 | -10.96% |
| Mar 31, 2025 | 8.52% |
| Dec 31, 2024 | -4.87% |
| Sep 30, 2024 | 2.66% |
| Jun 30, 2024 | -15.45% |
| Mar 31, 2024 | -29.86% |
| Dec 31, 2023 | -13.86% |
| Sep 30, 2023 | -49.19% |
| Jun 30, 2023 | -28.79% |
| Mar 31, 2023 | -35.19% |
| Dec 31, 2022 | -36.69% |
| Sep 30, 2022 | -7.81% |
| Jun 30, 2022 | -24.31% |
| Mar 31, 2022 | -22.71% |
| Dec 31, 2021 | -24.94% |
| Sep 30, 2021 | -20.01% |
| Jun 30, 2021 | 5.03% |
| Mar 31, 2021 | 32.54% |